Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobius Investm. Regulatory News (MMIT)

Share Price Information for Mobius Investm. (MMIT)

Share Price is delayed by 15 minutes
Get Live Data
184.00    1.00 (0.55%)
Bid:
182.00
Ask:
185.00
Spread: 3.00 (1.648%)
Market Cap: £120.87m
MMIT Live PriceLast checked at - London Stock Exchange

Intraday Mobius Investm. Share Chart

Directorate change

4 Feb 2026 07:00

RNS Number : 5941R
Mobius Investment Trust PLC
04 February 2026
 

4 February 2026

 

Mobius Investment Trust plc

("MMIT" or the "Company")

 

Directorate Changes

 

New Chair of the Company following Annual General Meeting ("AGM")

 

The Board of Mobius Investment Trust plc announces that the Chair, Maria Luisa Cicognani has communicated to the Board that she does not intend to stand for re-election at the next AGM and will resign from her position as independent non-executive Director and Chair of the Company with effect from the conclusion of the 2026 AGM expected to be held on 13 April 2026 (the "2026 AGM").

 

Maria Luisa has been an independent member of the Board since the Company's IPO in 2018 and will be stepping down as part of MMIT's succession planning. The Board thanks Maria Luisa for her support during these years and her invaluable contribution to the Company and wishes her continuing success in her other roles.

 

The Board of the Company is pleased to announce that Mr Gyula Schuch will take over as Chairman of the Company with effect from the conclusion of the 2026 AGM.

 

Gyula has been an independent non-executive Director of MMIT and Chairman of the Management Engagement and Remuneration Committee since 1 June 2022 and, since 13 January 2025, he has been Senior Independent Director. He will continue as Senior Independent Director and Chairman of the Management Engagement and Remuneration Committee until the conclusion of the 2026 AGM.

 

Senior Independent Director

 

Mrs Diana Dyer Bartlett, Chair of the Audit Committee, has been be appointed as the Company's new Senior Independent Director with effect from the conclusion of the 2026 AGM.

 

Appointment of new Director

 

The Board of Mobius Investment Trust plc is pleased to announce the appointment of Ms Sophie Wright as an independent non-executive director of the Company, with effect from 1 April 2026.

 

Sophie has over 30 years' experience of risk management, governance and process improvement leadership in the Financial Services sector, 25 years of which in International Investment banks (BNP Paribas, ABN Amro and JP Morgan). She held various senior executive roles at BNP Paribas Investment Bank in London from 1998 to 2017, notably as UK Lead for Operational Risk management for the European Interest Rate activity, and UK internal auditor in charge for the Wealth Management activity.

 

Since 2020, Sophie has served as Risk & Strategy Adviser with various Professional Membership organisations, as well as independent non-executive member of Finance and Risk Management boards and committees. She is currently an independent member of the Risk Management Board, Chair of the Risk Management Lifelong learning committee, and member of the Designated Professional Body board at the Institute & Faculty of Actuaries in London. She is also an independent member of the Audit, Risk and Investment Committee at Engineering UK.

 

Sophie is an electronic engineering graduate and holder of an MBA from London Business School.

 

There is no further information to be disclosed under UK Listing Rule 6.4.8(R).

 

Sophie has also been appointed to the Company's Audit Committee and Management Engagement and Remuneration Committee with effect from 1 April 2026. She will stand for election by shareholders at the 2026 AGM and will take over from Gyula Schuch as Chair of the Management Engagement and Remuneration Committee with effect from the conclusion of the 2026 AGM.

 

Maria Luisa Cicognani commented:

 

"My fellow directors and I are delighted to welcome Sophie Wright to the Board of MMIT. We are very pleased to have appointed a director with extensive risk, strategy, governance and financial services expertise. Sophie will be a great addition to the Board, and she will bring a wealth of experience in the sector. I am happy to see that following my departure the Company will continue with an experienced independent Board to take forward the Company's strategy in the interest of all our shareholders".

 

- ENDS-

 

For further information please contact:

 

Kerstin Rucht

Frostrow Capital LLP, Company Secretary

020 3709 8732

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUQCPUPQGMW
Date   Source Headline
22nd Dec 202511:43 amRNSNet Asset Value(s)
19th Dec 20251:37 pmRNSNet Asset Value(s)
19th Dec 202510:44 amRNSMonthly Factsheet as at 30 November 2025
19th Dec 202510:44 amRNSMonthly Factsheet as at 30 November 2025
18th Dec 20251:47 pmRNSNet Asset Value(s)
17th Dec 202512:05 pmRNSNet Asset Value(s)
16th Dec 202512:17 pmRNSNet Asset Value(s)
15th Dec 20251:08 pmRNSNet Asset Value(s)
12th Dec 20252:31 pmRNSNet Asset Value(s)
11th Dec 20251:36 pmRNSNet Asset Value(s)
10th Dec 202512:23 pmRNSNet Asset Value(s)
9th Dec 202512:12 pmRNSNet Asset Value(s)
8th Dec 202512:14 pmRNSNet Asset Value(s)
5th Dec 20251:55 pmRNSNet Asset Value(s)
4th Dec 20254:01 pmRNSHolding(s) in Company
4th Dec 20253:59 pmRNSNet Asset Value(s)
4th Dec 20252:23 pmRNSDirector/PDMR Shareholding
3rd Dec 20255:38 pmRNSHolding(s) in Company
3rd Dec 20255:03 pmRNSNet Asset Value(s)
2nd Dec 20254:13 pmRNSNet Asset Value(s)
2nd Dec 20257:00 amRNSVoluntary Redemption of Ordinary Shares and TVR
1st Dec 20254:20 pmRNSNet Asset Value(s)
28th Nov 20251:29 pmRNSNet Asset Value(s)
27th Nov 20251:57 pmRNSNet Asset Value(s)
26th Nov 202512:23 pmRNSNet Asset Value(s)
25th Nov 202511:45 amRNSNet Asset Value(s)
24th Nov 202512:31 pmRNSNet Asset Value(s)
24th Nov 20259:55 amRNSDirector/PDMR Shareholding
21st Nov 202512:04 pmRNSNet Asset Value(s)
21st Nov 202511:56 amRNSMonthly Factsheet as at 31 October 2025
20th Nov 202512:42 pmRNSNet Asset Value(s)
19th Nov 202512:53 pmRNSNet Asset Value(s)
18th Nov 202511:38 amRNSNet Asset Value(s)
17th Nov 20251:36 pmRNSNet Asset Value(s)
14th Nov 202512:04 pmRNSNet Asset Value(s)
13th Nov 20252:13 pmRNSNet Asset Value(s)
12th Nov 20251:07 pmRNSNet Asset Value(s)
11th Nov 202512:36 pmRNSNet Asset Value(s)
10th Nov 202512:54 pmRNSNet Asset Value(s)
7th Nov 202512:38 pmRNSNet Asset Value(s)
6th Nov 202512:21 pmRNSNet Asset Value(s)
5th Nov 202511:47 amRNSNet Asset Value(s)
4th Nov 202512:21 pmRNSNet Asset Value(s)
4th Nov 20257:00 amRNSVoluntary Redemption of Ordinary Shares
3rd Nov 20251:12 pmRNSNet Asset Value(s)
3rd Nov 20259:24 amRNSTotal Voting Rights
31st Oct 20251:35 pmRNSNet Asset Value(s)
30th Oct 20253:03 pmRNSNet Asset Value(s)
29th Oct 202512:34 pmRNSNet Asset Value(s)
28th Oct 202512:27 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.